Thermoregulatory Phenotype of the Trpv1 Knockout Mouse: Thermoeffector Dysbalance with Hyperkinesis

被引:97
作者
Garami, Andras [1 ]
Pakai, Eszter [1 ]
Oliveira, Daniela L. [1 ]
Steiner, Alexandre A. [1 ]
Wanner, Samuel P. [1 ,2 ]
Almeida, M. Camila [1 ]
Lesnikov, Vladimir A. [3 ]
Gavva, Narender R. [4 ]
Romanovsky, Andrej A. [1 ]
机构
[1] St Josephs Hosp, Syst Inflammat Lab, Phoenix, AZ 85013 USA
[2] Univ Fed Minas Gerais, Dept Physiol & Biophys, BR-31270901 Belo Horizonte, MG, Brazil
[3] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[4] Amgen Inc, Dept Neurosci, Newbury Pk, CA 91320 USA
基金
美国国家卫生研究院;
关键词
VANILLOID RECEPTOR-1 TRPV1; BODY-TEMPERATURE; CANNABINOID RECEPTOR; CAPSAICIN RECEPTOR; IN-VIVO; PHARMACOLOGICAL-ACTIVITY; AMBIENT-TEMPERATURE; DEFICIENT MICE; FULL AGONIST; PAIN PATHWAY;
D O I
10.1523/JNEUROSCI.4671-10.2011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study aimed at determining the thermoregulatory phenotype of mice lacking transient receptor potential vanilloid-1 (TRPV1) channels. We used Trpv1 knockout (KO) mice and their genetically unaltered littermates to study diurnal variations in deep body temperature (T-b) and thermoeffector activities under basal conditions, as well as thermoregulatory responses to severe heat and cold. Only subtle alterations were found in the basal T-b of Trpv1 KO mice or in their T-b responses to thermal challenges. The main thermoregulatory abnormality of Trpv1 KO mice was a different pattern of thermoeffectors used to regulate T-b. On the autonomic side, Trpv1 KO mice were hypometabolic (had a lower oxygen consumption) and hypervasoconstricted (had a lower tail skin temperature). In agreement with the enhanced skin vasoconstriction, Trpv1 KO mice had a higher thermoneutral zone. On the behavioral side, Trpv1 KO mice preferred a lower ambient temperature and expressed a higher locomotor activity. Experiments with pharmacological TRPV1 agonists (resiniferatoxin and anandamide) and a TRPV1 antagonist (AMG0347) confirmed that TRPV1 channels located outside the brain tonically inhibit locomotor activity. With age (observed for up to 14 months), the body mass of Trpv1 KO mice exceeded that of controls, sometimes approaching 60 g. In summary, Trpv1 KO mice possess a distinct thermoregulatory phenotype, which is coupled with a predisposition to age-associated overweight and includes hypometabolism, enhanced skin vasoconstriction, decreased thermopreferendum, and hyperkinesis. The latter may be one of the primary deficiencies in Trpv1 KO mice. We propose that TRPV1-mediated signals from the periphery tonically suppress the general locomotor activity.
引用
收藏
页码:1721 / 1733
页数:13
相关论文
共 72 条
  • [51] Thermoregulatory responses to lipopolysaccharide in the mouse: dependence on the dose and ambient temperature
    Rudaya, AY
    Steiner, AA
    Robbins, JR
    Dragic, AS
    Romanovsky, AA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2005, 289 (05) : R1244 - R1252
  • [52] Contribution of TRPV channels to osmosensory transduction, thirst, and vasopressin release
    Sharif-Naeini, R.
    Ciura, S.
    Zhang, Z.
    Bourque, C. W.
    [J]. KIDNEY INTERNATIONAL, 2008, 73 (07) : 811 - 815
  • [53] The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
    Smart, D
    Gunthorpe, MJ
    Jerman, JC
    Nasir, S
    Gray, J
    Muir, AI
    Chambers, JK
    Randall, AD
    Davis, JB
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (02) : 227 - 230
  • [54] SMITH PB, 1994, J PHARMACOL EXP THER, V270, P219
  • [55] Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications
    Snitker, Soren
    Fujishima, Yoshiyuki
    Shen, Haiqing
    Ott, Sandy
    Pi-Sunyer, Xavier
    Furuhata, Yasufumi
    Sato, Hitoshi
    Takahashi, Michio
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2009, 89 (01) : 45 - 50
  • [56] Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors
    Steiner, Alexandre A.
    Turek, Victoria F.
    Almeida, Maria C.
    Burmeister, Jeffrey J.
    Oliveira, Daniela L.
    Roberts, Jennifer L.
    Bannon, Anthony W.
    Norman, Mark H.
    Louis, Jean-Claude
    Treanor, James J. S.
    Gavva, Narender R.
    Romanovsky, Andrej A.
    [J]. JOURNAL OF NEUROSCIENCE, 2007, 27 (28) : 7459 - 7468
  • [57] The emerging role of TRPV1 in diabetes and obesity
    Suri, Anish
    Szallasi, Arpad
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2008, 29 (01) : 29 - 36
  • [58] Vanilloid (capsaicin) receptors in the rat: Distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment
    Szallasi, A
    Nilsson, S
    FarkasSzallasi, T
    Blumberg, PM
    Hokfelt, T
    Lundberg, JM
    [J]. BRAIN RESEARCH, 1995, 703 (1-2) : 175 - 183
  • [59] The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
    Szallasi A.
    Cortright D.N.
    Blum C.A.
    Eid S.R.
    [J]. Nature Reviews Drug Discovery, 2007, 6 (5) : 357 - 372
  • [60] Daily body temperature rhythm and heat tolerance in TRPV1 knockout and capsaicin pretreated mice
    Szelényi, Z
    Hummel, Z
    Szolcsányi, J
    Davis, JB
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 19 (05) : 1421 - 1424